Symbols

DMAC

Diamedica·NASDAQ

--(--)

DMAC Filings

2026-04-01 ·

Form ARS - Annual Report to Security Holders

2026-04-01 · Key Events

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-04-01 · Key Events

Form DEF 14A - Other definitive proxy statements

2026-03-31 · Earnings Call

DiaMedica Therapeutics Inc. (DMAC) Q4 2025 Earnings Call Transcript

2026-03-31 · Key Events

Form 8-K - Current report

2026-03-30 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-02-17 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-17 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-02-06 ·

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

2026-01-06 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities